Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Alzheimer's / Dementia News

Executive Cognitive Function In CADASIL Patients May Be Improved By Taking Donepezil

rate icon Editor's Choice
Main Category: Alzheimer's / Dementia
Also Included In: Stroke;  Neurology / Neuroscience;  Clinical Trials / Drug Trials
Article Date: 26 Feb 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions


Current Article Ratings:

Patient / Public:3 and a half stars

3.33 (3 votes)

Health Professional:4 and a half stars

4.5 (2 votes)

Article Opinions: 0 posts

According to an article published in the April edition of The Lancet Neurology, donepezil may improve the executive function of patients who suffer from the CADASIL form of vascular dementia. However, researcher Martin Dichgans of Ludwig Maximilian University, Munich, Germany and colleagues found that donepezil did not improve patients' cognitive score.

CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is a genetic form of vascular dementia (due to vascular lesions in the brain) and the most common form of hereditary stroke disorder. It tends to begin with migraine headaches and strokes in middle-aged patients. Executive functions are the high-level cognitive processes that facilitate new ways of behaving, and optimize one's approach to unfamiliar circumstances.

Donepezil is a type of cholinesterase inhibitor (CI) that can benefit functions of brain, body, and daily living activities in patients with mild to moderate Alzheimer's disease (AD). In the elderly, it is quite common to have AD along with vascular dementia. One of the difficulties in testing CI drugs is due to the fact that it is not clear whether the drug benefits have been caused by improvement in the vascular dementia or the AD. Since CADASIL has early onset in patients, it is possible to study people who only have CADASIL, without overlapping AD symptoms.

Dichgans and colleagues studied 168 patients in randomized controlled setting, all who had CADASIL and were between 25 and 70 years of age. The focus was to see if donepezil improved cognitive function. Over 18 weeks, 86 participants received 10 mg donepezil each day and 82 received placebo.

Main findings include:
"Donepezil had no effect on the primary endpoint, the V-ADAS-cog score in CADASIL patients with cognitive impairment. Improvements were noted on several measures of executive function, but the clinical relevance of these findings is not clear," write the authors. Dichgans and colleagues note, however, that their findings can aid future trial design in subcortical vascular cognitive impairment.

An accompanying Reflection and Reaction written by Lon S. Schneider of University of Southern California Keck School of Medicine, Los Angeles, CA writes: "Dichgans and colleagues showed the feasibility of multi-center trials with patients with CADASIL and the therapeutic potential of cholinesterase inhibitors. In future trials, the sample selection should be reconsidered to define better the cognitive impairment syndrome to be treated, choose outcomes that reflect the deficits to be treated, and identify the individual patients who benefit from treatment."

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL
The Lancet Neurology. February 22, 2008.
doi:10.1016/S1474-4422(08)70046-2
Click Here to View Abstract

Written by: Peter M Crosta
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
Long-Held Theory About Biological Clocks Overturned By U-M Discovery
09 Oct 2009
University of Michigan mathematicians and their British colleagues say they have identified the signal that the brain sends to the rest of the body to control biological rhythms, a finding that overturns a long-held theory about our internal clock...


The Role of a Caregiver image The Role of a Caregiver

When a frail or chronically ill loved one can no longer care for him or herself the issue confronting families is what to do about care. Learn what you need to think about first...

Using Creativity to Combat Alzheimer's image Using Creativity to Combat Alzheimer's

Learn how the introduction of a new activity changed the lives of an Alzheimer's patient and her caregiver...

View more videos...